Literature DB >> 18540808

Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity.

Monique A S H Mennink-Kersten, Dorien Ruegebrink, Paul E Verweij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18540808     DOI： 10.1086/588563

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  38 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Authors:  Alessandra Mularoni; Elisa Furfaro; Maura Faraci; Alessia Franceschi; Paola Mezzano; Roberto Bandettini; Claudio Viscoli; Elio Castagnola
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

3.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

4.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

5.  Strategy for overcoming serum interferences in detection of serum (1,3)-β-D-glucans.

Authors:  Boualem Sendid; Nadine Francois; Vanessa Decool; Julien Poissy; Daniel Poulain
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

6.  Invasive fungal infections in acute leukemia.

Authors:  Vijaya R Bhatt; George M Viola; Alessandra Ferrajoli
Journal:  Ther Adv Hematol       Date:  2011-08

Review 7.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.

Authors:  G Lo Cascio; R Koncan; G Stringari; A Russo; A Azzini; A Ugolini; M Ligozzi; E Polati; G Cornaglia; E Concia; V Schweiger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-13       Impact factor: 3.267

9.  Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.

Authors:  Ahmed H Fahal; Malcolm A Finkelman; Yonglong Zhang; Wendy W J van de Sande
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

10.  Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.

Authors:  E Furfaro; M Mikulska; V Del Bono; F Guolo; P Minetto; M Gobbi; A Ghiso; A Bacigalupo; C Viscoli
Journal:  Clin Vaccine Immunol       Date:  2014-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.